Side Effects & Safety·August 18, 2026·10 min read
With a uterus, no: the estradiol label itself instructs adding a progestin, because unopposed estrogen carries about 2- to 12-fold the endometrial cancer risk of non-users. After a hysterectomy, generally yes, with one exception the label names. The fork, the risk numbers, bedtime dosing, and the peanut-oil catch.
Read the guide
Side Effects & Safety·August 18, 2026·12 min read
Irregular bleeding or spotting in the first months of continuous HRT is common enough that the FDA labels chart it: about 86% of women were bleed-free by month 12 in Activella's trial. Bleeding that persists, returns after a bleed-free stretch, or shows up off HRT entirely gets an endometrial workup. The split, with the label numbers and what the workup actually involves.
Read the guide
Side Effects & Safety·August 4, 2026·7 min read
The randomized trial that asked this directly found women on hormone therapy gained 1.0 kg LESS than placebo over three years, with 1.2 cm less waist increase. The estradiol patch label shows no dose-response either: weight increase peaks at the lowest dose and hits 0% at the highest.
Read the guide
Side Effects & Safety·July 6, 2026·12 min read
In February 2026 the FDA removed the boxed warning from menopausal hormone therapy. Here's what changed, why the old Women's Health Initiative warnings misled a generation of women, who HRT is right and wrong for, and the real risks that remain. Every claim primary-sourced.
Read the guide